Sfoglia per Rivista HAEMATOLOGICA
Targeted activation of the SHP-1/PP2A signaling axis elicits apoptosis of chronic lymphocytic leukemia cells
2017-01-01 Tibaldi, E.; Pagano, M. A.; Frezzato, F.; Trimarco, V.; Facco, M.; Zagotto, G.; Ribaudo, G.; Pavan, V.; Bordin, L.; Visentin, A.; Zonta, F.; Semenzato, G.; Brunati, A. M.; Trentin, L.
Targeting HRASV12G Expression to the Zebrafish Early Hemogenic Progenitors Induces a Myeloproliferative Disorder by Repressing the Notch Pathway.
2012-01-01 Alghisi, Elisa; Malagola, Michele; Santoriello, C; Distel, M; Henkel, C; Skert, C; Filì, C; Bergonzi, C; Perucca, Simone; Turra, Alessandro; DI PALMA, Andrea; Cancelli, Valeria; Ribolla, R; Cattina, Federica; Zedda, S; Bernardi, Simona; Russo, Domenico
Thalidomide in the treatment of patients with myelodysplastic syndromes or smouldering acute myeloid leukemia.
2003-01-01 Finelli, C; Piccaluga, Pp; Martinelli, G; Visani, G; Malagola, Michele; El Cheick, J; Vigna, E; Rondoni, M; Gaitani, S; Bosi, C; Dizdari, A; Grafone, T; Ascani, S; Pileri, S; Baccarani, M.
The achievement of molecular complete remission during treatment with Imatinib mesylate correlates with relapse free survival in bcr/abl-positive acute lymphoid leukemia patients.
2004-01-01 Piccaluga, Pp; Malagola, Michele; Amabile, M; Rondoni, M; Paolini, S; Pane, F; Russo, Domenico; Visani, G; Baccarani, M.; Martinelli, G.
The development of more than one histologic type of lymphoma in the same patient is frequent and confers a worse prognosis.
2005-01-01 Tucci, A; Motta, M; Ungari, M; Ruggeri, G; Crippa, C; Borlenghi, E; Ubiali, A; Facchetti, Fabio; Rossi, G.
The histone deacetylase inhibitor ITF2357 (Givinostat) promotes Burkitt’s lymphoma cell line death modulating micro-RNA and Tissue Transglutaminase 2 expression
2009-01-01 Di Nicola, M.; Zappasodi, R.; Baldan, F.; Iorio, M. V.; Magni, M.; Tagliabue, E.; Giacomini, A; Croce, C. M.; Carlo- Stella, C.; Gianni, A. M.
Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling. Implications for transferrin-dependent hepcidin regulation.
2010-01-01 Poli, M; Luscieti, Sara; Gandini, V.; Maccarinelli, Federica; Finazzi, Dario; Silvestri, L.; Roetto, A.; Arosio, Paolo
Treatment of early stage B-cell chronic lymphocytic leukemia with alpha-interferon
1991-01-01 Gallizia, C.; Fanin, R.; Patriarca, F.; Russo, Domenico; Baccarani, M.
Treatment of patients with chronic myeloid leukemia (CML) resistant to imatinib
2009-01-01 Russo, D.; Malagola, M.; Colombi, C.
Two more inv(16) acute myeloid leukemia cases with infrequent CBFalpha-MYH11 fusion transcript: clinical and molecular findings.
2002-01-01 Martinelli, G; Ottaviani, E; Buonamici, S; Isidori, A; Malagola, Michele; Piccaluga, Pp; Baccarani, M.
Update of cytogenetic and molecular response in 88 elderly PH+ chronic myeloid leukemia patients enrolled in the phase II explorative study of intermittent imatinib (IM) treatment (INTERIM).
2010-01-01 Russo, Domenico; G., Rosti; G., Martinelli; Malagola, Michele; S., Mirto; D., Turri; M., Gobbi; I., Pierri; U., Vitolo; P., Pregno; E., Morra; E., Pungolino; F., Di Raimondo; F., Stagno; R., Foà; G., Alimena; M., Breccia; F., Nobile; B., Martino; A., Rambaldi; T., Intermesoli; G., Saglio; G., Rege Cambrin; G., Visani; G., Nicolini; P., De Fabritiis; E., Abruzzese; R., Fanin; M., Tiribelli; P., Galieni; C., Bigazzi; V., Liso; G., Specchia; E., Angelucci; E., Usala; C., Musolino; S., Russo; G., Gaidano; M., Lunghi; F., Lauria; M., Bocchia; A., D’Emilio; A., Bosi; V., Sanitini; G., Quarta; M., Girasoli; G., Fioritoni; R., Di Lorenzo; C., Colombi; M., Fogli; 2 M., Amabile; N., Testoni; A., De Vivo; M., Baccarani
[Update on the prognosis of chronic myeloid leukemia]
1989-01-01 Baccarani, M; Russo, D; Zuffa, E; Tassinari, A; Fanin, R; Zaccaria, A
Validation and molecular integration of the RR6 model to predict survival after 6 months of therapy with ruxolitinib
2024-01-01 Coltro, G.; Capecchi, G.; Maffioli, M.; Mannelli, F.; Mora, B.; Atanasio, A.; Iurlo, A.; Maccari, C.; Farina, M.; Nacca, E.; Caramella, M.; Signori, L.; Borella, M.; Bertù, L.; Esposito, M.; Guglielmelli, P.; Passamonti, F.; Vannucchi, A. M.
Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions.
2007-01-01 Ferreri, Aj; Dognini, Gp; Campo, E; Willemze, R; Seymour, Jf; Bairey, O; Martelli, M; DE RENZ, Ao; Doglioni, C; Montalban, C; Tedeschi, A; Pavlovsky, A; Morgan, S; Uziel, L; Ferracci, M; Ascani, S; Gianelli, U; Patriarca, C; Facchetti, Fabio; DALLA LIBERA, A; Pertoldi, B; Horvath, B; Szomor, A; Zucca, E; Cavalli, F; Ponzoni, M.
WT-1 FROM PERIPHERAL BLOOD PREDICTS RELAPSE IN AML PATIENTS UNDERGOING STEM CELL TRANSPLANTATION
2014-01-01 Malagola, Michele; Skert, C; Ribolla, R; Cattina, F; Cancelli, V; Turra, A; Schieppati, F; Bergonzi, C; Fili, C; Ruggeri, G; Russo, Domenico
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Targeted activation of the SHP-1/PP2A signaling axis elicits apoptosis of chronic lymphocytic leukemia cells | 1-gen-2017 | Tibaldi, E.; Pagano, M. A.; Frezzato, F.; Trimarco, V.; Facco, M.; Zagotto, G.; Ribaudo, G.; Pavan, V.; Bordin, L.; Visentin, A.; Zonta, F.; Semenzato, G.; Brunati, A. M.; Trentin, L. | |
| Targeting HRASV12G Expression to the Zebrafish Early Hemogenic Progenitors Induces a Myeloproliferative Disorder by Repressing the Notch Pathway. | 1-gen-2012 | Alghisi, Elisa; Malagola, Michele; Santoriello, C; Distel, M; Henkel, C; Skert, C; Filì, C; Bergonzi, C; Perucca, Simone; Turra, Alessandro; DI PALMA, Andrea; Cancelli, Valeria; Ribolla, R; Cattina, Federica; Zedda, S; Bernardi, Simona; Russo, Domenico | |
| Thalidomide in the treatment of patients with myelodysplastic syndromes or smouldering acute myeloid leukemia. | 1-gen-2003 | Finelli, C; Piccaluga, Pp; Martinelli, G; Visani, G; Malagola, Michele; El Cheick, J; Vigna, E; Rondoni, M; Gaitani, S; Bosi, C; Dizdari, A; Grafone, T; Ascani, S; Pileri, S; Baccarani, M. | |
| The achievement of molecular complete remission during treatment with Imatinib mesylate correlates with relapse free survival in bcr/abl-positive acute lymphoid leukemia patients. | 1-gen-2004 | Piccaluga, Pp; Malagola, Michele; Amabile, M; Rondoni, M; Paolini, S; Pane, F; Russo, Domenico; Visani, G; Baccarani, M.; Martinelli, G. | |
| The development of more than one histologic type of lymphoma in the same patient is frequent and confers a worse prognosis. | 1-gen-2005 | Tucci, A; Motta, M; Ungari, M; Ruggeri, G; Crippa, C; Borlenghi, E; Ubiali, A; Facchetti, Fabio; Rossi, G. | |
| The histone deacetylase inhibitor ITF2357 (Givinostat) promotes Burkitt’s lymphoma cell line death modulating micro-RNA and Tissue Transglutaminase 2 expression | 1-gen-2009 | Di Nicola, M.; Zappasodi, R.; Baldan, F.; Iorio, M. V.; Magni, M.; Tagliabue, E.; Giacomini, A; Croce, C. M.; Carlo- Stella, C.; Gianni, A. M. | |
| Transferrin receptor 2 and HFE regulate furin expression via mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/Erk) signaling. Implications for transferrin-dependent hepcidin regulation. | 1-gen-2010 | Poli, M; Luscieti, Sara; Gandini, V.; Maccarinelli, Federica; Finazzi, Dario; Silvestri, L.; Roetto, A.; Arosio, Paolo | |
| Treatment of early stage B-cell chronic lymphocytic leukemia with alpha-interferon | 1-gen-1991 | Gallizia, C.; Fanin, R.; Patriarca, F.; Russo, Domenico; Baccarani, M. | |
| Treatment of patients with chronic myeloid leukemia (CML) resistant to imatinib | 1-gen-2009 | Russo, D.; Malagola, M.; Colombi, C. | |
| Two more inv(16) acute myeloid leukemia cases with infrequent CBFalpha-MYH11 fusion transcript: clinical and molecular findings. | 1-gen-2002 | Martinelli, G; Ottaviani, E; Buonamici, S; Isidori, A; Malagola, Michele; Piccaluga, Pp; Baccarani, M. | |
| Update of cytogenetic and molecular response in 88 elderly PH+ chronic myeloid leukemia patients enrolled in the phase II explorative study of intermittent imatinib (IM) treatment (INTERIM). | 1-gen-2010 | Russo, Domenico; G., Rosti; G., Martinelli; Malagola, Michele; S., Mirto; D., Turri; M., Gobbi; I., Pierri; U., Vitolo; P., Pregno; E., Morra; E., Pungolino; F., Di Raimondo; F., Stagno; R., Foà; G., Alimena; M., Breccia; F., Nobile; B., Martino; A., Rambaldi; T., Intermesoli; G., Saglio; G., Rege Cambrin; G., Visani; G., Nicolini; P., De Fabritiis; E., Abruzzese; R., Fanin; M., Tiribelli; P., Galieni; C., Bigazzi; V., Liso; G., Specchia; E., Angelucci; E., Usala; C., Musolino; S., Russo; G., Gaidano; M., Lunghi; F., Lauria; M., Bocchia; A., D’Emilio; A., Bosi; V., Sanitini; G., Quarta; M., Girasoli; G., Fioritoni; R., Di Lorenzo; C., Colombi; M., Fogli; 2 M., Amabile; N., Testoni; A., De Vivo; M., Baccarani | |
| [Update on the prognosis of chronic myeloid leukemia] | 1-gen-1989 | Baccarani, M; Russo, D; Zuffa, E; Tassinari, A; Fanin, R; Zaccaria, A | |
| Validation and molecular integration of the RR6 model to predict survival after 6 months of therapy with ruxolitinib | 1-gen-2024 | Coltro, G.; Capecchi, G.; Maffioli, M.; Mannelli, F.; Mora, B.; Atanasio, A.; Iurlo, A.; Maccari, C.; Farina, M.; Nacca, E.; Caramella, M.; Signori, L.; Borella, M.; Bertù, L.; Esposito, M.; Guglielmelli, P.; Passamonti, F.; Vannucchi, A. M. | |
| Variations in clinical presentation, frequency of hemophagocytosis and clinical behavior of intravascular lymphoma diagnosed in different geographical regions. | 1-gen-2007 | Ferreri, Aj; Dognini, Gp; Campo, E; Willemze, R; Seymour, Jf; Bairey, O; Martelli, M; DE RENZ, Ao; Doglioni, C; Montalban, C; Tedeschi, A; Pavlovsky, A; Morgan, S; Uziel, L; Ferracci, M; Ascani, S; Gianelli, U; Patriarca, C; Facchetti, Fabio; DALLA LIBERA, A; Pertoldi, B; Horvath, B; Szomor, A; Zucca, E; Cavalli, F; Ponzoni, M. | |
| WT-1 FROM PERIPHERAL BLOOD PREDICTS RELAPSE IN AML PATIENTS UNDERGOING STEM CELL TRANSPLANTATION | 1-gen-2014 | Malagola, Michele; Skert, C; Ribolla, R; Cattina, F; Cancelli, V; Turra, A; Schieppati, F; Bergonzi, C; Fili, C; Ruggeri, G; Russo, Domenico |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile